Methylene Blue 10mg 60 Oral Capsules

Methylene blue (methylthioninium chloride) is an established pharmaceutical compound, first synthesized in 1876 and FDA‑approved in clinical contexts such as methemoglobinemia and cyanide poisoning. In low oral doses, it has been studied as a mitochondrial electron shuttle and antioxidant, with research examining its role in cellular ATP generation and in lowering reactive oxygen species (ROS). This unique dual role has sparked increased interest in research into its potential to support energy metabolism, cognitive performance, cellular resilience, and longevity, especially in the context of neurodegenerative disorders and aging.